Furthermore, an in vivo study involving a kidney disease model demonstrated that pharmacological inhibition of FXa by edoxaban attenuated tubulointerstitial fibrosis, macrophage infiltration, and inflammatory molecule upregulation in unilateral ureteral obstruction43. The gene discussed is F10; the disease is kidney disorder.